Interim FDG-PET/CT for Response Assessment of Lymphoma. Zeman MN, Akin EA, Merryman RW, Jacene HA, et al. Semin Nucl Med 2022 Nov 11. pii: S0001-2998(22)00092.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zeman MN, Akin EA, Merryman RW, Jacene HA, et al. Interim FDG-PET/CT for Response Assessment of Lymphoma. Semin Nucl Med 2022 Nov 11. pii: S0001-2998(22)00092.
PMID: 36376131